title: Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor.
abstract: The signal pathway for control of apoptosis in human neutrophils is currently unknown. In this study, we provide the first evidence that a Src family tyrosine kinase, Lyn, plays a key role in inhibition polymorphonuclear (PMN) cell death. Several nuclear proteins associated with apoptosis, i.e., p53, cdc2, and Rb, were absent from PMN. Bcl-2, known to inhibit apoptosis, was also not expressed. Programmed cell death that rapidly occurred in PMN could be arrested by granulocyte-macrophage CSF (GM-CSF), but this activation did not induce p53, cdc2, retinoblastoma, or Bcl-2 expression. Instead, GM-CSF produced a rapid activation of Lyn and Hck, but not Fgr, tyrosine phosphorylation within 1 min. Co-immunoprecipitation studies indicated that only Lyn, but not Hck, was physically coupled to GM-CSF receptor. By histologic assessment and evaluation of DNA fragmentation, only antisense Lyn, but not antisense Hck or antisense Fgr, could reverse the cell survival advantage provided by GM-CSF. Therefore, the physical coupling of Lyn to GM-CSF receptor and its early activation are required for inhibition or delay of apoptosis in PMN.
authors.affiliation: Immunology Program, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida College of Medicine, Tampa 33612, USA.
authors.forename: S
authors.initials: S
authors.lastname: Wei
authors.forename: J H
authors.initials: JH
authors.lastname: Liu
authors.forename: P K
authors.initials: PK
authors.lastname: Epling-Burnette
authors.forename: A M
authors.initials: AM
authors.lastname: Gamero
authors.forename: D
authors.initials: D
authors.lastname: Ussery
authors.forename: E W
authors.initials: EW
authors.lastname: Pearson
authors.forename: M E
authors.initials: ME
authors.lastname: Elkabani
authors.forename: J I
authors.initials: JI
authors.lastname: Diaz
authors.forename: J Y
authors.initials: JY
authors.lastname: Djeu
mesh_terms: D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology*; D001483:Base Sequence; D004789:Enzyme Activation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology*; D016376:Oligonucleotides, Antisense / Q000235:genetics; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051572:Proto-Oncogene Proteins c-hck; D011994:Recombinant Proteins; D015398:Signal Transduction / Q000502:physiology; D019061:src-Family Kinases / Q000235:genetics / Q000502:physiology*
chemical_list: D016376:Oligonucleotides, Antisense; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D011505:Protein-Tyrosine Kinases; C496631:HCK protein, human; D051572:Proto-Oncogene Proteins c-hck; C060902:lyn protein-tyrosine kinase; D019061:src-Family Kinases